New Compound Tied to Clinical Benefit in PBC

LONDON (MedPage Today) -- The investigational compound obeticholic acid holds promise for people with primary biliary cirrhosis (PBC) -- the first new potential treatment in 2 decades, a researcher said here.
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news